Twenty Years’ Experience With Minimally Invasive Aortic Valve Repair
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf294 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Razan Salem und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, University Hospital and Goethe University, 60596 Frankfurt/Main, Germany. Hauptthemen laut MEDLINE: Minimally Invasive Surgical Procedures, Aortic Valve, Aortic Valve Insufficiency, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objectives
Aortic valve repair (AVr) has become the preferred strategy to treat patients with significant aortic valve incompetence at experienced centres. Minimally invasive AVr (MIAVr) has not yet been widely adopted due to its higher technical complexity; thus, we aim to present our long-term results.
Methods
From 2000 to 2022, 308 patients with a median age of 56 (20-83) years (25.9% female) received MIAVr through upper ministernotomy. Follow-up data were evaluated using Kaplan-Meier and competing risk analysis.
Results
Conversion to sternotomy was required in 3 patients (1%), and 1 patient (0.3%) suffered a perioperative stroke. Thirty-day mortality was 0.3%. During follow-up, 29 patients required aortic valve reoperation. The cumulative incidence of reoperation was estimated at 4.1% (95% CI, 2.4%-7.2%) at 5 years, 11.7% (95% CI, 8.3%-16.3%) at 10 years, and 15.8% (95% CI, 11.5%-21.4%) at 15 years. The overall estimated cumulative incidence of recurrent AR ≥ moderate was 12.1% (95% CI, 9.2%-16.0%) at 5 years, 18.7% (95% CI, 15.0%-23.2%) at 10 years, and 23.0% (95% CI, 18.8%-28.1%) at 15 years. The estimated overall survival was 90.7% (95% CI, 87.2%-94.2%) at 5 years, 79.3% (95% CI, 73.8%-85.1%) at 10 years, and 63.4% (95% CI, 53.9%-74.7%) at 15 years.
Conclusions
MIAVr is safe and reproducible with very good long-term valve performance. Minimally invasive access does not compromise long-term durability and valve performance after AVr.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, University Hospital and Goethe University, 60596 Frankfurt/Main, Germany.
ORCID-Profile: Razan Salem, Tomas Holubec
Zitieren
APA
Salem, R., Rashid, H., Karimian-Tabrizi, A., Hlavicka, J., von Zeppelin, M., Winter, A., Miskovic, A., Moritz, A., Walther, T., & Holubec, T. (2025). Twenty Years’ Experience With Minimally Invasive Aortic Valve Repair. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf294
Vancouver
Salem R, Rashid H, Karimian-Tabrizi A, Hlavicka J, von Zeppelin M, Winter A, et al. Twenty Years’ Experience With Minimally Invasive Aortic Valve Repair. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf294
BibTeX
@article{Salem2025,
author = {Salem, Razan and Rashid, Hiwad and Karimian-Tabrizi, Afsaneh and Hlavicka, Jan and von Zeppelin, Mascha and Winter, Andreas and Miskovic, Alexandra and Moritz, Anton and Walther, Thomas and Holubec, Tomas},
title = {Twenty Years’ Experience With Minimally Invasive Aortic Valve Repair},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf294}
}
EUVIMED